CGEN-913

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCGEN-913
Drug Alias NameAnti-CGEN-913 antibody (Compugen)CGEN-913
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammationMultiple MyelomaLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCompugen Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCompugen Ltd
Active IndicationsN/A
Inactive IndicationsInflammationMultiple MyelomaLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A
Related LinksN/A